GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Advanced Solid Tumor · Metastatic Solid Tumor · Cervical Cancer · Urothelial Carcinoma · Clear Cell Renal Cell Cancer (ccRCC) · Squamous Cell Non Small Cell Lung Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Tisch Cancer Institute (TCI), Icahn School of Medicine, New York, New York, United States

    Contact: Principal Investigator (Thomas Marron, MD, PhD)
  • Carolina Biooncology Institute, Huntersville, North Carolina, United States

    Contact: Principal Investigator (John Powderly, M.D., Ph.D.)
  • The Catholic University of Korea Seoul ST.MARY'S Hospital, Seoul, Banpo-daero, South Korea

    Contact: Principal Investigator (In Ho Kim)
  • Seoul National University Bundang Hospital, Seoul, Bundang-gu, South Korea

    Contact: Principal Investigator (EunHee Jung)
  • Chungnam National University Hospital, Daejeon, Daejeon, South Korea

    Contact: Principal Investigator (HyoJin Lee, M.D., Ph.D.)
  • Samsung Medical Center, Seoul, Gangnam, South Korea

    Contact: Principal Investigator (Se Hoon Park)
  • The Catholic University of Korea St. Vincent's Hospital, Suwon, Kyeonggi-do, South Korea

    Contact: Principal Investigator (Byoung-Yong Shim, M.D., Ph.D.)
  • Korea University Anam Hospital, Seoul, Seongbuk-gu, South Korea

    Contact: Principal Investigator (SooHyeon Lee, M.D.)
  • Ewha Womans University Mokdong Hospital, Seoul, Yangcheon-gu, South Korea

    Contact: Principal Investigator (Jeong Min Cho)
  • Yonsei University Health System, Severance Hospital, Seoul, South Korea

    Contact: Principal Investigator (Byoung Chul Cho, M.D., Ph.D.)
    Sang Joon Shin, M.D., Ph.D. (Sub-investigator)
  • Yonsei University Health System, Severance Hospital, Seoul, South Korea

    Contact: Principal Investigator (Jung-Yun Lee, M.D., Ph.D.)
  • Asan Medical Center, Seoul, South Korea

    Contact: Principal Investigator (Jae Lyun Lee, M.D., Ph.D.)
מובילי המחקר
  • Nari Yun, PhD

    Study Director

    GI Innovation